Sign in

CIK 0001472091

  • Non-accelerated filer
  • Smaller reporting company

PDS Biotechnology Corp

Sign in to watch
Ticker
PDSB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
264231384
Phone
+1 800-208-3343
Business address
303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
Edge Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 27 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-03-15 BLECH ISAAC Director Option exercise +10,000 10,000
2019-03-15 BLECH ISAAC Director Option exercise · Restricted Stock Units −10,000 0
2019-03-15 BLECH ISAAC Director Option exercise +10,000 10,000
2019-03-15 BLECH ISAAC Director Option exercise · Restricted Stock Units −10,000 0
2018-08-14 BLECH ISAAC Director Grant or award · Restricted Stock Units +10,000 10,000
2018-06-19 BLECH ISAAC Director Grant or award · Stock Option (Right To Purchase) +20,000 20,000
2017-06-20 BLECH ISAAC Director Grant or award · Stock Option (right To Purchase) +15,000 $10.15 $152K 15,000
2016-06-21 BLECH ISAAC Director Grant or award · Stock Option (right To Purchase) +15,000 15,000

Page 1 of 1 · 8 trades